semaglutide chemical structure | GLP-1 receptor agonist | 910463-68-2 Semaglutide: Definition, Structure, Mechanism of

Dr Parag Sheth, Regional Director-Regulatory & Medical at Abbott, said original is produced via recombinant DNA biotechnology, while many upcoming products use synthetic peptide processes that differ significantly

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

For this reason, DSIP is most often studied in the context of sleep architecture, stress regulation, and neuroendocrine balance rather than as a pure sleep-onset agent

High NNMT expression is significantly associated with unfavorable prognosis